8-K: NeuroPace 2026 Annual Meeting Voting Results

NeuroPace stockholders elected Class II directors and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for 2026.

Summary

• NeuroPace held its 2026 Annual Meeting of Stockholders on June 5, 2026.
• Stockholders elected Lisa Andrade and Scott Huennekens as Class II directors to serve until the 2029 Annual Meeting.
• The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the filing reports standard procedural outcomes from an annual shareholder meeting.

Positives

• Successful election of board nominees ensures continuity of corporate governance.
• Strong shareholder support for the ratification of the independent auditor, with 28,850,105 votes in favor.

Negatives

• Director nominee Lisa Andrade received a significant number of withhold votes (6,024,133) compared to the other nominee.

Risks

• Potential for shareholder dissatisfaction indicated by the withhold votes for specific board members.

Future Outlook

No specific forward-looking financial guidance was provided in this filing, as it pertains strictly to the results of the annual meeting.

Industry Context

StockSavvy.ai notes that routine annual meeting filings are standard for publicly traded medical device companies, reflecting stable corporate governance practices.

Comparison to Industry Standards

• The ratification of auditors and election of directors are standard procedural requirements for Nasdaq-listed companies.
• The voting turnout and results are consistent with typical corporate governance cycles for mid-cap healthcare firms.

Corporate Governance

Stakeholder Impact

• Shareholders have confirmed the board and auditor appointments for the upcoming cycle.

Next Steps

• Directors will serve until the 2029 Annual Meeting.
• PricewaterhouseCoopers LLP will continue as the independent auditor for the 2026 fiscal year.

Key Dates

Keywords

NeuroPace, NPCE, Annual Meeting, Proxy Voting, Corporate Governance, Board Election